DNA vaccines for viral diseases

Microbes and Infection

Volumn 1, Issue 1, 1999, Pages 7-21

  Davis, Heather L ^a   McCluskie, Michael J ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Animal models; DNA vaccines; Genetic vaccination; Infectious disease; Therapeutic immunization

Indexed keywords

DNA VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; MEASLES VACCINE; RABIES VACCINE; RECOMBINANT INTERLEUKIN 12; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CELLULAR IMMUNITY; DRUG COST; DRUG FORMULATION; DRUG MECHANISM; HUMAN; IMMUNOSTIMULATION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS INFECTION;

ANIMALIA; HEPATITIS C VIRUS;

EID: 0032820550     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80009-4     Document Type: Article

References (189)

1. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465.
2. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152.
3. Schirmbeck R., Reimann J. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur. J. Immunol. 24:1994;1478.
4. Guidotti L.G., Ando K., Hobbs M.V., Ishikawa T., Runkel L., Schreiber R.D., Chisari F.V. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;3764.
5. Schirmbeck R., Melber K., Kuhröber A., Janowicz Z.A. Jr. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1994;1110.
6. Lanzavecchia A. Identifying strategies for immune intervention. Science. 260:1993;937.
7. World Health Organization. Potential use of live viral and bacterial vectors for vaccines, WHO meeting, Geneva, 19-22 June, 1989. Vaccine. 8:1990;425.
8. Davis H.L., Mancini M., Michel M.L., Whalen R.G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine. 14:1996;910.
9. Davis H.L., Schleef M., Moritz P., Mancini M., Schorr J., Whalen R.G. Comparison of plasmid DNA preparation methods for direct gene transfer and genetic immunization. Biotechniques. 21:1996;92.
10. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA. 93:1996;2879.
11. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352.
12. Bueler H., Mulligan R.C. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol. M. 2:1996;545.
13. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:1997;169.
14. Geissler M., Gesien A., Tokushige K., Wands J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1997;1231.
15. Hakim I., Levy S., Levy R. A nine-amino acid peptide from IL-1 beta augments antitumor immune responses induced by protein and DNA vaccines. J. Immunol. 157:1996;5503.
16. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:1997;4591.
17. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816.
18. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., Mahalingam S., Dang K., Ahn L., Doyle N.K., Wilson D.M., Chattergoon M.A., Chalian A.A., Boyer J.D., Agadjanyan M.G., Weiner D.B. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28:1998;1089.
19. Mahvi D.M., Burkholder J.K., Turner J., Culp J., Malter J.S., Sondel P.M., Yang N.S. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum. Gene Ther. 7:1996;1535.
20. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638.
21. Tsuji T., Hamajima K., Ishii N., Aoki I., Fukushima J., Xin K.Q., Kawamoto S., Sasaki S., Matsunaga K., Ishigatsubo Y., Tani K., Okubo T., Okuda K. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. 27:1997;782.
22. Kim J.J., Bagarazzi M.L., Trivedi N., Hu Y., Kazahaya K., Wilson D.M., Ciccarelli R., Chattergoon M.A., Dang K., Mahalingam S., Chalian A.A., Agadjanyan M.G., Boyer J.D., Wang B., Weiner D.B. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotechnol. 15:1997;641.
23. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:1997;9563.
24. Pardo O.L., Peligrino J.L., Guzman M.G., Guillen G. Immunization of mice with DNA encoding the pr-M protein from dengue-2 virus. Proceedings of the EC/FDA/NIAID/WHO Meeting on Nucleic Acid Vaccines for the Prevention of Infectious Diseases. 1996.
25. Sariol C.A., Pardo O.L., Giraldo S., Pelegrino J.L., Guillen G., Guzman M.G. Immunization of mice with DNA encoding the envelope protein from dengue-2 virus. Proceedings of the EC/FDA/NIAID/WHO Meeting on Nucleic Acid Vaccines for the Prevention of Infectious Diseases. 1996.
26. Kochel T., Wu S.J., Raviprakash K., Hobart P., Hoffman S., Porter K., Hayes C. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine. 15:1997;547.
27. Xu L., Sanchez A., Yang Z., Zaki S.R., Nabel E.G., Nichol S.T., Nabel G.J. Immunization for Ebola virus infection. Nature M. 4:1998;37.
28. Davis H.L., Demeneix B.A., Quantin B., Coulombe J., Whalen R.G. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle, Hum. Gene Ther. 4:1993;733.
29. Davis H.L., McCluskie M.J., Gerin J.L., Purcell R.H. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA. 93:1996;7213.
30. Geissler M., Tokushige K., Chante C.C., Zurawski V.R. Jr, Wands J.R. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology. 112:1997;1307.
31. Michel M.L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA. 92:1995;5307.
32. Prince A.M., Whalen R., Brotman B. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine. 15:1997;916.
33. Schirmbeck R., Bohm W., Ando K., Chisari F.V., Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in non-responder mice. J. Virol. 69:1995;5929.
34. Kuhrober A., Wild J., Pudollek H.P., Chisari F.V., Reimann J. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int. Immunol. 9:1997;1203.
35. Gregoriadis G., Saffie R., DeSouza J.B. Liposome-mediated DNA vaccination. FEBS Lett. 402:1997;107.
36. Inchauspe G., Vitvitski L., Major M.E., Jung G., Spengler U., Maisonnas M., Trepo C. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell. Biol. 16:1997;185.
37. Lagging L.M., Meyer K., Hoft D., Houghton M., Belshe R.B., Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:1995;5859.
38. Major M.E., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trepo C., Inchauspe G. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:1995;5798.
39. Saito T., Sherman G.J., Kurokohchi K., Guo Z.P., Donets M., Yu M.Y., Berzofsky J.A., Akatsuka T., Feinstone S.M. Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology. 112:1997;1321.
40. Tedeschi V., Akatsuka T., Shih J.W., Battegay M., Feinstone S.M. A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2. Hepatology. 25:1997;459.
41. Tokushige K., Wakita T., Pachuk C., Moradpour N., Weiner D.B., Zurawski V.R. Jr, Wands J.R. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology. 24:1996;14.
42. Polo J.M., Lim B., Govindarajan S., Lai M.M. Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J. Virol. 69:1995;5203.
43. He J., Hoffman S.L., Hayes C.G. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine. 15:1997;357.
44. Ghias H., Cai S., Slanina S., Nesburn A.B., Wechsler S.L. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28:1995;147.
45. Manickan E., Rouse R.J., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:1995;259.
46. Bourne N., Milligan G.N., Schleiss M.R., Bernstein D.I., Stanberry L.R. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine. 14:1996;1230.
47. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:1997;3138.
48. Bourne N., Stanberry L.R., Bernstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:1996;800.
49. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA. 93:1996;11414.
50. Kriesel J.D., Spruance S.L., Daynes R.A., Araneo B.A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 173:1996;536.
51. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature M. 3:1997;526.
52. Liu M.A., Yasutomi Y., Davies M.E., Perry H.C., Freed D.C., Letvin N.L., Shiver J.W. Vaccination of mice and nonhuman primates using HIV-gene-containing DNA. Antibiot. Chemother. 48:1996;100.
53. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., Robinson H.L. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology. 209:1995;147.
54. Okuda K., Bukawa H., Hamajima K., Kawamoto S., Sekigawa K., Yamada Y., Tanaka S., Ishi N., Aoki I., Nakamura M. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res. Hum. Retroviruses. 11:1995;933.
55. Shiver J.W., Davies M.E., Perry H.C., Freed D.C., Liu M.A. Humoral and cellular immunities elicited by HIV-1 vaccination. J. Pharmacol. Sci. 85:1996;1317.
56. Shiver J.W., Davies M.E., Yasutomi Y., Perry H.C., Freed D.C., Letvin N.L., Liu M.A. Anti-HIV env immunities elicited by nucleic acid vaccines. Vaccine. 15:1997;884.
57. Tobery T.W., Siliciano R.F. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. M. 185:1997;909.
58. Wang B., Boyer J., Srikantan V., Coney L., Carrano R., Phan C., Merva M., Dang K., Agadjanan M., Gilbert L., Ugen K.E., Williams W.V., Weiner D.B. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell. Biol. 12:1993;799.
59. Wang B., Ugen K.E., Srikantin V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A.I., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA. 90:1993;4156.
60. Wang B., Boyer J., Srikantan V., Ugen K., Agadjanian M., Merva M., Gilbert L., Dang K., McCallus D., Moelling K. DNA inoculation induces cross clade anti-HIV-1 responses. Ann. N.Y. Acad. Sci. 772:1995;186.
61. Williams W.V., Boyer J.D., Merva M., Livolsi V., Wilson D., Wang B., Weiner D.B. Genetic infection induces protective in vivo immune response. DNA Cell. Biol. 12:1993;675.
62. Donnelly J.J., Martinez D., Jansen K.U., Ellis R.W., Montgomery D.L., Liu M.A. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 173:1996;314.
63. Ugen K., Agadjanyan M., Wang B., Weiner D. DNA inoculation against HTLV-1. Proceedings of the EC/FDA/NIAID/WHO Meeting on Nucleic Acid Vaccines for the Prevention of Infectious Diseases. 1996.
64. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature M. 1:1995;583.
65. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478.
66. Fynan E.F., Robinson H.L., Webster R.G. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell. Biol. 12:1993;785.
67. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17:1995;79.
68. Justewicz D.M., Morin M.J., Robinson H.L., Webster R.G. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J. Virol. 69:1995;7712.
69. Justewicz D.M., Webster R.G. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology. 224:1996;10.
70. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., Ulmer J.B., Donnelly J.J., Liu M.A. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA. Cell. Biol. 12:1993;777.
71. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119.
72. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957.
73. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745.
74. Yankauckas M.A., Morrow J.E., Parker S.E., Abai A., Rhodes G.H., Dwarki V.J., Gromkowski S.H. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell. Biol. 12:1993;771.
75. Lin Y.L., Chen L.K., Liao C.L., Yeh C.T., Ma S.H., Chen J.L., Huang Y.L., Chen S.S., Chiang H.Y. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72:1998;191.
76. Cardoso A.I., Blixenkrone-Moller M., Fayolle J., Liu M., Buckland R., Wild T.F. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology. 225:1996;293.
77. Cardoso A.I., Sixt N., Vallier A., Fayolle J., Buckland R., Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen. J. Virol. 72:1998;2516.
78. Fooks A.R., Jeevarajah D., Warnes A., Wilkinson G.W., Clegg J.C. Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene. Viral. Immunol. 9:1996;65.
79. Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P.H., Siegrist C.A. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA. 94:1997;8726.
80. Etchart N., Buckland R., Liu M.A., Wild T.F., Kaiserlian D. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78:1997;1577.
81. Herrmann J.E., Chen S.C., Fynan E.F., Santoro J.C., Greenberg H.B., Robinson H.L. DNA vaccines against rotavirus infections. Arch. Virol. (Suppl.12):1996;207.
82. Herrmann J.E., Chen S.C., Fynan E.F., Santoro J.C., Greenberg H.B., Wang S., Robinson H.L. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 174:1996;S93-S93.
83. Chen S.C., Fynan E.F., Robinson H.L., Lu S., Greenberg H.B., Santoro J.C., Herrmann J.E. Protective immunity induced by rotavirus DNA vaccines. Vaccine. 15:1997;899.
84. Phillpotts R.J., Venugopal K., Brooks T. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol. 141:1996;743.
85. Romito M., Du Plessis D.H., Van, Kleef M., VanWyk A., Viljoen G.J. DNA-based immunization of a horse using the VP2 gene of african horsesickness virus. Proceedings of the EC/FDA/NIAID/WHO Meeting on Nucleic Acid Vaccines for the Prevention of Infectious Diseases. 1996.
86. Cox G.J.M., Zamb T.J., Babiuk L.A. Bovine herpes virus 1: immune response in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664.
87. Suradhat S., Yoo D., Babiuk L.A., Griebel P., Baca-Estrada M.E. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice. Viral Immunol. 10:1997;117.
88. Harpin S., Talbot B., Mbikay M., Elazhary Y. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 146:1997;229.
89. Sundaram P., Xiao W., Brandsma J.L. Particle-mediated delivery of recombinant expression vectors to rabbit skin induces high-titered polyclonal antisera (and circumvents purification of a protein immunogen). Nucleic Acids Res. 24:1996;1375.
90. Sundaram P., Tigelaar R.E., Brandsma J.L. Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge. Vaccine. 15:1997;664.
91. Triyatni M., Jilbert A.R., Qiao M., Miller D.S., Burrell C.J. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72:1998;84.
92. Rigby M.A., Hosie M.J., Willett B.J., Mackay N., McDonald M., Cannon C., Dunsford T., Jarrett O., Neil J.C. Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Res. Hum. Retroviruses. 13:1997;405.
93. Cuisinier A.M., Mallet V., Meyer A., Caldora C., Aubert A. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus. Vaccine. 15:1997;1085.
94. Sparger E.E., Louie H., Ziomeck A.M., Luciw P.A. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone. Virology. 238:1997;157.
95. Richardson J., Moraillon A., Baud S., Cuisinier A.M., Sonigo P., Pancino G. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J. Virol. 71:1997;9640.
96. Ward G., Rieder E., Mason P.W. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J. Virol. 71:1997;7442.
97. Anderson E.D., Mourich D.V., Fahrenkrug S.C., LaPatra S., Shepherd J., Leong J.A. Genetic immunization of rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus. Mol. Mar. Biol. Biotechnol. 5:1996;114.
98. Olsen C.W., Mc Gregor M.W., Dybdahl-Sissoko N., Schram B.R., Nelson K.M., Lunn D.P., Macklin M.D., Swain W.F., Hinshaw V.S. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice. Vaccine. 15:1997;1149.
99. Haynes J.R., McCabe D.E., Swain W.F., Widera G., Fuller J.T. Particle-mediated nucleic acid immunization. J. Biotechnol. 44:1996;37.
100. Martins L.P., Lau L.L., Asano M.S., Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 69:1995;2574.
101. Yokoyama M., Zhang J., Whitton J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684.
102. Zarozinski C.C., Fynan E.F., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010.
103. Hassett D.E., Zhang J., Whitton J.L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881.
104. GonzalezArmas J.C., Morello C.S., Cranmer L.D., Spector D.H. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 70:1996;7921.
105. Sarzotti M., Dean T.A., Remington M.P., Ly C.D., Furth P.A., Robbins D.S. Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine. 15:1997;795.
106. Sakaguchi M., Nakamura H., Sonoda K., Hamada F., Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine. 14:1996;747.
107. Pirzadeh B., Dea S. Immune response in pigs vaccinated with plasmid DNA encoding Orf5 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 79:1998;989.
108. Monteil M., LePotier M.F., Guillotin J., Cariolet R., Houdayer C., Eloit M. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet. Res. 27:1996;443.
109. LePotier M.F., Monteil M., Houdayer C., Eloit M. Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies. Vet. Microbiol. 55:1997;75.
110. Gerdts V., Jons A., Makoschey B., Visser N., Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen. Virol. 78:1997;2139.
111. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132.
112. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.C. Immune responses to nucleic acid vaccines to rabies virus. Virology. 209:1995;569.
113. Ray N.B., Ewalt L.C., Lodmell D.L. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine. 15:1997;892.
114. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:1996;3978.
115. Lu S., Manson K., Wyand M., Robinson H.L. SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups. Vaccine. 15:1997;920.
116. Yasutomi Y., Robinson H.L., Lu S., Mustafa F., Lekutis C., Arthos J., Mullins J.I., Voss G., Manson K., Wyand M., Letvin N.L. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:1996;678.
117. Robinson H.L., Lu S., Mustafa F., Johnson E., Santoro J.C., Arthos J., Winsink J., Mullins J.I., Montefiori D., Yasutomi Y. Simian immunodeficiency virus DNA vaccine trial in macaques. Ann. N.Y. Acad. Sci. 772:1995;209.
118. Fuller D.H., Murphey-Corb M., Clements J., Barnett S., Haynes J.R. Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25:1996;236.
119. Fuller D.H., Simpson L., Cole K.S., Clements J.E., Panicali D.L., Montelaro R.C., Murphey-Corb M., Haynes J.R. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol. Cell Biol. 75:1997;389.
120. Wagener S., Norley S., zurMegede J., Kurth R., Cichutek K. Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs. J. Biotechnol. 44:1996;59.
121. Heppell J., Lorenzen N., Lorenzen E., Jensen K.E., Wu T., Davis H.L. Development of DNA vaccines for fish: vector design, antigen expression and demonstration of efficacy using viral haemorrhagic septicaemia virus as model. Fish Shellfish Immunol. 1998;. in press.
122. Lorenzen N., Lorenzen E., Einer-Jensen K., Heppell J., Davis H.L. Protective immunity to VHS in rainbow trout (Oncorhynchus mykissWalbaum) following DNA vaccination. Fish Shellfish Immunol. 1998;. in press.
123. Hinrichs J., Berger S., Shaw J.G. Induction of antibodies to plant viral proteins by DNA-based immunization. J. Virol. Methods. 66:1997;195.
124. Keller E.T., Burkholder J.K., Shi F., Pugh T.D., McCabe D., Malter J.S., Macewen E.G., Yang N.S., Ershler W.B. In vivo particle-mediated cytokine gene transfer into canine oral mucosa and epidermis. Cancer Gene Ther. 3:1996;186.
125. Livingston J.B., Lu S., Robinson H., Anderson D.J. Immunization of the female genital tract with a DNA-based vaccine. Infect. Immunol. 66:1998;322.
126. Jones D.H., Corris S., McDonald S., Clegg J.C., Farrar G.H. Poly (DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:1997;814.
127. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410.
128. Mannino R.J., Gould-Fogerite S. Lipid matrix-based vaccines for mucosal and systemic immunization. Powell M.F, Newman M.J. Vaccine Design; The subunit and adjuvant approach. 1995;363 Plenum Press, New York.
129. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., Baird S.M., Rhodes G.H. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA. 91:1994;9519.
130. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. M. 2:1996;1122.
131. Gramzinski R.A., Millan C.L.B., Obaldia N., Hoffman S.L., Davis H.L. Immune response to a hepatitis B DNA vaccine in Aotus monkeys - A comparison of vaccine formulation, route, and method of administration. Mol. M. 4:1998;109.
132. Ishii N., Fukushima J., Kaneko T., Okada E., Tani K., Tanaka S.I., Hamajima K., Xin K.Q., Kawamoto S., Koff W., Nishioka K., Yasuda T., Okuda K. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 13:1997;1421.
133. Yokoyama M., Zhang J., Whitton J.L. DNA immunization: Effects of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol. Med. Microbiol. 14:1996;221.
134. Liu Y., Mounkes L.C., Liggitt H.D., Brown C.S., Solodin I., Heath T.D., Debs R.J. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol. 15:1996;167.
135. Hinkula J., Lundholm P., Wahren B. Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine. 15:1997;874.
136. Wang B., Dang K., Agadjanyan M.G., Srikantan V., Li F., Ugen K.E., Boyer J., Merva M., Williams W.V., Weiner D.B. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine. 15:1997;821.
137. Bagarazzi M.L., Boyer J.D., Javadian M.A., Chattergoon M., Dang K., Kim G., Shah J., Wang B., Weiner D.B. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. J. Med. Primatol. 26:1997;27.
138. Nabel E.G., Shum L., Pompili V.J., Yang Z., San H., Shu H., Liptay S., Gold L., Gordon D., Derynck R., Nabel G.J. Direct transfer of transforming growth factor Beta-1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA. 90:1993;10759.
139. Masuda I., Matsuo T., Yasuda T., Matsuo N. Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest. Opthalmol. Vis. Sci. 37:1996;1914.
140. Tanelian D.L., Barry M.A., Johnston S.A., Le T., Smith G. Controlled gene gun delivery and expression of DNA within the cornea. Biotechniques. 23:1997;484.
141. Ulmer J.B., Deck R.R., Dewitt C.M., Fu T.M., Donnelly J.J., Caulfield M.J., Liu M.A. Expression of a viral protein in muscle cells in vivo induces protective cell-mediated immunity. Immunology. 89:1996;59.
142. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. M. 184:1996;1555.
143. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA. 93:1996;8578.
144. Iwasaki A., Torres C.A., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:1997;11.
145. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529.
146. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:1992;363.
147. Davis H.L., Brazolot-Millan C.L., Watkins S.C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4:1997;181.
148. Gray D., Kosaco M., Stockinger B. Novel pathways of antigen presentation for the maintenance of memory. Int. Immunol. 3:1991;141.
149. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546.
150. Halpern M.D., Kurlander R.J., Pisetsky D.S. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell. Immunol. 167:1996;72.
151. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84:1997;185.
152. Cowdery J.S., Chace J.H., Yi A.K., Krieg A.M. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 148:1996;4570.
153. Yamamoto S., Yamamoto Y., Kataoka T., Kuramoto E., Yano O., Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J. Immunol. 157:1992;4072.
154. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 160:1996;1840.
155. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA Is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 12:1998;870.
156. Davis H.L., Michel M.L., Mancini M., Schleef M., Whalen R.G. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine. 179:1994;1503.
157. Haynes J.R., Fuller D.F., McCabe D., Swain W.F., Widera G. Induction and characterization of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunization. Adv. Drug Del. Rev. 179:1996;3.
158. Leclerc C., Deriaud E., Rojas M., Whalen R.G. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell. Immunol. 772:1997;97.
159. Shiver J.W., Perry H.C., Davies M.E., Freed D.C., Liu M.A. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann. N.Y. Acad. Sci. 90:1995;198.
160. Tsuji T., Fukushima J., Hamajima K., Ishii N., Aoki I., Bukawa H., Ishigatsubo Y., Tani K., Okubo T., Dorf M.E., Okuda K. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology. 66:1997;1.
161. Sasaki S., Hamajima K., Fukushima J., Ihata A., Ishii N., Gorai I., Hirahara F., Mohri H., Okuda K. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. Infect. Immunol. 92:1998;823.
162. Toda S., Ishii N., Okada E., Kusakabe K.I., Arai H., Hamajima K., Gorai I., Nishioka K., Okuda K. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody. Immunology. 158:1997;111.
163. Lekutis C., Shiver J.W., Liu M.A., Letvin N.L. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. J. Immunol. 158:1997;4471.
164. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278.
165. Bot A., Antohi S., Bot S., Garcia-Sastre A., Bona C. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int. Immunol. 9:1997;1641.
166. Ulmer J.B., Deck R.R., DeWitt C.M., Donnelly J.J., Friedman A., Montgomery D.L., Yawman A.M., Orme I.M., Denis O., Content J., Huygen K., Liu M.A. Induction of immunity by DNA vaccination: application to influenza and tuberculosis. Behring Inst. Mitt. 1997;79.
167. Mor G., Klinman D.M., Shapiro S., Hagiwara E., Sedegah M., Norman J.A., Hoffman S.L., Steinberg A.D. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoeliicircumsporozoite protein plasmid DNA. J. Immunol. 155:1995;2039.
168. Dupre L., Poulain-Godefroy O., Ban E., Ivanoff N., Mekranfar M., Schacht A.M., Capron A., Riveau G. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol. 19:1997;505.
169. Lozes E., Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Vandenbussche P., VanVooren J.P., Drowart A., Ulmer J.B., Liu M.A. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine. 15:1997;830.
170. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., Swain S.L., Spiegelberg H.L., Carson D.A. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:1996;5141.
171. Attanasio R., Pehler K., Scinicariello F. DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes. FEMS Immunol. Med. Microbiol. 17:1997;207.
172. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 15:1997;788.
173. Kovarik J., Siegrist C.A. Immunity in early life. Immunol. Today. 19:1998;150.
174. Bot A., Bot S., Garcia-Sastre A., Bona C. DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. Viral Immunol. 9:1996;207.
175. Kiyono H., Miller C.J., Lu Y.C., Lehner T., Cranage M., Huang Y.T., Kawabata S., Marthas M., Roberts B., Nedrud J.G., Lamm M.E., Bergmeier L., Brookes R., Tao L., McGhee J.R. The common mucosal immune system for the reproductive tract- basic principles toward an AIDS vaccine. Adv. Drug Del. Rev. 18:1995;23.
176. Asakura Y., Hinkula J., Leandersson A.C., Fukushima J., Okuda K., Wahren B. Induction of HIV-1 specific mucosal immune responses by DNA vaccination. Scand. J. Immunol. 46:1997;326.
177. Babinet C., Farza H., Morello D., Hadchouel M., Pourcel C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science. 230:1985;1160.
178. Mancini M., Hadchouel M., Davis H.L., Whalen R.G., Tiollais P., Michel M.L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. USA. 93:1996;12496.
179. Rinaldo C., Huang X.L., Fan Z.F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:1995;5838.
180. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature M. 1:1995;59.
181. Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O.J., Demarest J.F., Montefiori D., Orenstein J.M., Fox C., Schrager L.K. Studies in subjects with long-term non-progressive human immunodeficiency virus infection. N. Engl. J. M. 332:1995;209.
182. Boyer J.D., Ugen K.E., Chattergoon M., Wang B., Shah A., Agadjanyan M., Bagarazzi M.L., Javadian A., Carrano R., Coney L., Williams W.V., Weiner D.B. DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees. J. Infect. Dis. 176:1997;1501.
183. Barnett S.W., Rajasekar S., Legg H., Doe B., Fuller D.H., Haynes J.R., Walker C.M., Steimer K.S. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine. 15:1997;869.
184. Boyer J.D., Wang B., Ugen K.E., Agadjanyan M., Javadian A., Frost P., Dang K., Carrano R.A., Ciccarelli R., Coney L., Williams W.V., Weiner D.B. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J. Med. Primatol. 25:1996;242.
185. Sasaki S., Tsuji T., Hamajima K., Fukushima J., Ishii N., Kaneko T., Xin K.Q., Mohri H., Aoki I., Okubo T., Nishioka K., Okuda K. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immunol. 65:1997;3520.
186. Nichols W.W., Ledwith B.J., Manam S.V., Troilo P.J. Potential DNA vaccine integration into host cell genome. Ann. N.Y. Acad. Sci. 772:1995;30.
187. Pisetsky D.S. Immunologic consequences of nucleic acid therapy. Antisense Res. Dev. 5:1995;219.
188. Pisetsky D.S. Immune activation by bacterial DNA: a new genetic code. Immunity. 5:1996;303.
189. Pisetsky D.S. Immunostimulatory DNA: a clear and present danger? Nat. M. 3:1997;82.